Phospholipidum essentiale
This medication should always be taken exactly as described in the patient leaflet or as advised by a doctor, pharmacist, or nurse.
Essentiale Forte is a plant-based medication used in liver diseases.
It contains essential phospholipids (Phospholipidum essentiale)that are glyceryl esters of choline phosphoric acid and unsaturated fatty acids: linoleic, linolenic, and oleic.
These phospholipids, due to their content of polyunsaturated fatty acids in the side chains, cannot be synthesized in the body.
The phospholipids contained in Essentiale Forte, after entering the liver, are incorporated into the membranes of liver cells. This leads to the replenishment of existing deficiencies resulting from the disease process and faster regeneration of damaged liver cells.
Phospholipids are essential in the process of differentiation and proliferation of liver cells.
They inhibit fibrosis processes in the liver by reducing collagen production and increasing the activity of the enzyme that breaks it down - collagenase.
The phospholipids incorporated into the membranes of liver cells reduce the sensitivity of these cells to factors of the immune system that may damage them.
Phospholipids are secreted into bile, where they reduce the cholesterol/phospholipid ratio and increase the solubility of cholesterol in it - thanks to the emulsifying properties of essential phospholipids, this has great importance in the prevention of gallstones.
Phospholipids, along with bile acids, play an important role in fat digestion and the absorption of fat-soluble vitamins.
Additionally, the polyunsaturated fatty acids that make up the phospholipids reduce cholesterol levels and normalize lipoprotein levels in serum - showing a beneficial anti-atherosclerotic effect. They also increase the transport of cholesterol from extrahepatic tissues to the liver and activate lipolytic enzymes. Polyunsaturated fatty acids improve blood flow in vessels by reducing platelet adhesion and increasing the elasticity of red blood cells.
Reduces subjective patient complaints such as: loss of appetite, feeling of pressure in the right upper abdomen caused by liver damage due to an improper diet, the action of toxic substances, or in the course of hepatitis.
Before starting to take Essentiale Forte, the patient should discuss it with their doctor or pharmacist.
If after 7 days there is no improvement, the patient feels worse, symptoms have worsened, or other non-specific symptoms have appeared, they should consult their doctor.
There is insufficient data on the use of Essentiale Forte in children under 12 years of age. Therefore, Essentiale Forte should not be used in children under 12 years of age.
The patient should tell their doctor or pharmacist about all medications they are currently taking or have recently taken, as well as any medications they plan to take.
Before taking Essentiale Forte with anticoagulant medications, the patient should consult their doctor.
Capsules should be taken during meals, without chewing (washing down, e.g., with a glass of water).
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medication.
Soybeans are often a component of food, and so far, no harmful effect on the course of pregnancy has been observed during their use. However, sufficient studies have not been conducted. In connection with the above, the use of this medication during pregnancy and breastfeeding is not recommended.
Essentiale Forte does not affect the ability to drive or operate machinery.
Due to the content of soybean oil, the medication may cause severe allergic reactions.
Do not use in case of known hypersensitivity to peanuts or soy.
This medication contains less than 1 mmol of sodium (23 mg) per dose, which means it is considered "sodium-free".
This medication contains 10 mg of alcohol (ethanol) in each capsule, which is equivalent to 20.49 mg/g (2.05% w/w).
The amount of ethanol in one capsule is equivalent to less than 1 ml of beer or 1 ml of wine.
The small amount of alcohol in this medication will not cause noticeable effects.
This medication should always be taken exactly as described in the patient leaflet or as advised by a doctor, pharmacist, or nurse. In case of doubt, the patient should consult their doctor, pharmacist, or nurse.
Adults and children over 12 years: 2 capsules 3 times a day.
Capsules should be taken during meals, without chewing (washing down, e.g., with a glass of water).
Essentially, there are no time limits for the use of Essentiale Forte, but the recommended treatment duration should be at least 1-3 months.
The duration of treatment may also be determined individually by the doctor.
There is insufficient data on the use of Essentiale Forte in children under 12 years of age. Therefore, Essentiale Forte should not be used in children under 12 years of age.
There have been no reported cases of Essentiale Forte overdose.
In the event of taking a higher dose of Essentiale Forte than recommended, the below-described side effects may be intensified.
Like all medications, Essentiale Forte can cause side effects, although not everybody gets them.
Frequency not known(frequency cannot be estimated from the available data):
an allergic reaction may occur, such as redness, rash, urticaria, itching, gastrointestinal disorders, e.g., nausea, vomiting, loose stools, diarrhea, discomfort in the abdominal cavity, increased blood pressure, palpitations, dizziness.
If any side effects occur, including any possible side effects not listed in this leaflet, the patient should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, more information can be collected on the safety of the medication.
The medication should be stored out of sight and reach of children.
Store in a temperature below 25°C, protect from moisture.
Do not use this medication after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medications should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medications that are no longer needed. This will help protect the environment.
Coating:gelatin, yellow iron oxide (E 172), black iron oxide (E 172), red iron oxide (E 172), titanium dioxide (E 171), sodium lauryl sulfate, purified water.
Yellow to brown paste of honey-like consistency in a green, opaque, elongated capsule.
The packaging contains 50, 90, 100, or 180 capsules.
Marketing Authorization Holder
Opella Healthcare Poland Sp. z o.o.
ul. Marcina Kasprzaka 6
01-211 Warsaw
{Sanofi logo}
Manufacturer
A.Nattermann & Cie. GmbH
Nattermannalee 1
D-50829 Cologne, Germany
Opella Healthcare Poland Sp. z o.o.
Branch in Rzeszów
ul. Lubelska 52
35-233 Rzeszów
To obtain more detailed information, please contact:
Opella Healthcare Poland Sp. z o.o.
ul. Marcina Kasprzaka 6
01-211 Warsaw
phone: +48 22 280 00 00
Date of last revision of the leaflet: June 2025
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.